Skip to content

ANAVEX LIFE SCIENCES CORP.

AVXL

CIK 0001314052

← back to feed
Revenue (TTM)
—
Q1 Feb 2026
Net Income (TTM)
−$42.23M
−7.8% YoY Q1 Feb 2026
EPS Diluted (TTM)
−$0.49
−3.8% YoY Q1 Feb 2026
Gross Margin
—
Q1 Feb 2026
Operating Margin
—
Q1 Feb 2026
Net Margin
—
Q1 Feb 2026
Free Cash Flow (TTM)
−$32.39M
Q1 Feb 2026
Cash
$131.75M
Q1 Feb 2026
Total Debt
$345
Q1 Feb 2026
Shares Outstanding
92.67M sh
Q1 Feb 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings